Nuclear DDX3 was previously described as a negative prognostic factor in FBC [25, 26], while cytoplasmic over-expression of DDX3 was found in FBC brain metastases of especially triple negative and high grade cases [16], but the prognostic value of DDX3 in MBC had not yet been studied. This evidence concerns the gene DDX3X and complete blood cell count.